Biochemical and Biophysical Research Communications (BBRC) is the premier international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. For short communication papers, we offer the fastest submission to acceptance of any journal within life sciences, with "accept" decisions rendered within three weeks of submission. We will now consider full-length research papers and review articles.

The journal covers most of areas of life science, and is divided into the following sections:
Biochemistry
Biophysics
Cell Biology
Cellular Pathology and Cancer
Computational Biology and Bioinformatics
Genetics
Immunology and Inflammation
Microbiology and Virology
Nanomedicine and Bionanomaterials
Neuroscience
Pharmacology
Physiology
Plant Biology
Structural Biology
Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.

Announcement: BBRC has traditionally only published short communications of novel results. From 2023, the journal now publishes short communications, full-length research papers, and reviews.

What type of paper should I choose on submission?

For short communications, we will still aim to make an accept or reject decision within two weeks of submission. If you have novel results that you can consolidate into 4,600 words, with no more than four figures, then you may continue to choose the short communication route.

Short communications should be concise, no more than 4,600 words and up to four display items. They should offer novel insights and warrant a rapid peer review process. The 4,600 word count includes the title page, all sections of the manuscript (including the references), and the figure and table legends. Papers that exceed these limits will be reassigned within the submission system as a full-length research paper.

If you submit a full-length research paper or a review paper, we will continue to offer a fast turnaround (with a decision after review within 30 days of submission), and we'll also make sure that any revisions that we request of you will not require significant resource expenditure on your part.

Full-length research papers should present a comprehensive account of original research. These papers are not restricted by length or number of figures.

Review papers should be authoritative, state-of-the-art accounts of the selected research field and be of high interest, balanced, and accurate. Beyond summaries of important scientific developments and ideas, authors are encouraged to identify and discuss how the field may be impacted or develop in the future, including insights that may be of significance to the scientific community. The number of co-authors of review articles is limited to five, and each author is expected to make a substantial contribution to the writing of the manuscript.

There are no restrictions on length for review papers, and we welcome both comprehensive reviews and short reviews that offer an insight into more recent advances in a field.

short communications
Special content
reviews
thematic issues

Editor-in-Chief
Wolfgang Baumeister, PhD
Max-Planck-Institute of Biochemistry, Martinsried, Germany
Email Wolfgang Baumeister, PhD
Structural Biology, Biophysics, Protein folding and degradation
Special Content Editor
Ernesto Carafoli
University of Padua, Padova, Italy
Email Ernesto Carafoli
Cell signaling, Calcium biochemistry, Bioenergetics, Mitochondria, Neuroscience
Managing Editor
Michael Lacy
Elsevier Inc, New York, New York, United States
Editors
Christoph Alexiou, MD
Christoph Alexiou, MD
Erlangen University Hospital, Erlangen, Germany
Email Christoph Alexiou, MD
Animal experiments, Imaging, Oncology, Regenerative Medicine (the Nanoscience related were: Nanomedicine, Nanoparticles: Synthesis-Characterisation-Application in biomedicine, Nanotoxicology, Cardiovascular Nanomedicine).
Ilya Bezprozvanny
Ilya Bezprozvanny
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, Dallas, United States
Email Ilya Bezprozvanny
Synapse, calcium signaling, neurodegeneration
Zengyi Chang
Zengyi Chang
Peking University, Beijing, China
Email Zengyi Chang
Protein Chemistry and Degradation
Chin Ha Chung
Seoul National University School of Biological Sciences, Seoul, Korea, Republic of
Email Chin Ha Chung
Enzymology; Protein Chemistry and Degradation
Vitaly Citovsky
Stony Brook University Department of Biochemistry and Cell Biology, Stony Brook, United States
Email Vitaly Citovsky
Gene Regulation and Chromatin Remodelling; Protein Degradation; Virology; Plant Biology
Bengt Fadeel
Karolinska Institute, Stockholm, Sweden
Email Bengt Fadeel
Inflammation; Nanoscience and Nanomedicine; Cell Death
Félix M. Goñi
Félix M. Goñi
University of the Basque Country Department of Biochemistry, Leioa, Spain
Email Félix M. Goñi
Barry Halliwell
Barry Halliwell
National University of Singapore, Singapore, Singapore
Email Barry Halliwell
Oxidative stress; Bioenergetics/Mitochondria; Molecular Toxicology
Hans Jörnvall
Karolinska Institute, Stockholm, Sweden
Email Hans Jörnvall
Structural Biology; Metabolism in Health and Disease; Lipid, Membrane and Membrane Proteins
Yong-Keun Jung
Yong-Keun Jung
Seoul National University School of Biological Sciences, Seoul, Korea, Republic of
Email Yong-Keun Jung
Apoptosis/cell death, Autophagy, Cell signaling, Neurodegenerative disease
Guido Kroemer
National Institute of Health and Medical Research, Paris, France
Email Guido Kroemer
Cancer Biology; Cell Death; Autophagy
M. Lichten
Bethesda, Maryland, United States
Email M. Lichten
DNA Repair and Recombination, Gene regulation and chromatin remodeling, Yeast Genetics and Epigenetics
Konstantin A. Lukyanov
Konstantin A. Lukyanov
Skolkovo Institute of Science and Technology, Skolkovo, Russian Federation
Email Konstantin A. Lukyanov
Fluorescent proteins, Fluorescence labeling and imaging, Super-resolution fluorescence microscopy, Bioluminescence, Optogenetics
Anders Lund
University of Copenhagen, København, Denmark
Email Anders Lund
MicroRNA; Epigenetics; Gene Regulation and Chromatin Remodelling
Carlos Martinez-A.
National Centre for Biotechnology, Madrid, Spain
Email Carlos Martinez-A.
Immunology and Inflammation; Cancer Research; Cell Biology
Hisao Masai
Tokyo Metropolitan Institute of Medical Science Department of Genome Medicine, Tokyo, Japan
Email Hisao Masai
Cell Signalling; DNA Repair and Recombination; Gene Regulation and Chromatin Remodelling
Katsuhiko Mikoshiba
ShanghaiTech University, Shanghai, China
Email Katsuhiko Mikoshiba
Neuroscience; Oxidative Stress and Antioxidants; Protein Folding
Davis Ng
National University of Singapore, Singapore, Singapore
Email Davis Ng
Glycobiology; Lipid, Membrane and Membrane Proteins; Protein Degradation; Protein Folding and Misfolding
James Ntambi
James Ntambi
University of Wisconsin Madison, Madison, United States
Email James Ntambi
Lipids, Metabolism, Biochemistry, Signaling, Diabetes, Obesity
Sergio Pantano
Sergio Pantano
Pasteur Montevideo Institute, Montevideo, Uruguay
Email Sergio Pantano
Computational/Structural Biology, Molecular Simulations, Bioinformatics
Duanqing Pei
Guangzhou Institutes of Biomedicine and Health, Guangzhou, China
Email Duanqing Pei
Jacques Pouysségur
Valrose Institute of Biology, Nice, France
Email Jacques Pouysségur
Hypoxia Signalling; Cancer Biology; Bioenergetics/Mitochondria
Luigia Santella
Zoological Station Anton Dohrn, Napoli, Italy
Email Luigia Santella
Fertilization and Early Development, Molecular Biology of Reproduction
Igor Stagljar
Igor Stagljar
University of Toronto, Toronto, Canada
Email Igor Stagljar
Cell Signalling; Cancer Biology; Functional Genomics; Lipid, Membrane and Membrane Proteins; Proteomics
Bing Su
Shanghai Jiao Tong University School of Medicine, Shanghai, China
Email Bing Su
MAPKs, mTOR, mTORC2, Sin1, inflammatory bowel diseases, autoimmune diseases, T cell regulation, immune receptor signalling
Kiyoshi Takatsu
University of Toyama Department of Immunobiology and Pharmacology, Toyama, Japan
Email Kiyoshi Takatsu
Immunology and Inflammation
Naoyuki Taniguchi
Osaka International Cancer Institute, Osaka, Japan
Email Naoyuki Taniguchi
Cell signalling; Cancer Biology; Extracellular Matrix
William Vainchenker
William Vainchenker
Gustave Roussy, Villejuif, France
Email William Vainchenker
Liping Wang
Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences, Shenzhen, China
Email Liping Wang
Eric Westhof
Eric Westhof
Institute of Molecular and Cellular Biology, Strasbourg, France
Email Eric Westhof
Relationships between sequences, three-dimensional structures, evolution and functions of RNA molecules, especially those with catalytic activity
Isaac P. Witz
Tel Aviv University, Tel Aviv, Israel
Email Isaac P. Witz
Cancer Biology; Stem cells
Alec Zhang
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, Dallas, United States
Email Alec Zhang
Surface receptors and signaling, cancer, cancer immunology, and stem cells
Boris Zhivotovsky
Boris Zhivotovsky
Karolinska Institute, Stockholm, Sweden
Email Boris Zhivotovsky
Apoptosis/Cell Death; Authophagy, Cancer Biology